1-6 of 6
Prashant Ramesh Tembhare
Close
Sort by
Journal Articles

Circulating Clonal Plasma Cells at Diagnosis and Peripheral Blood Measurable Residual Disease Assessment Provide Powerful Prognostication Biomarkers in Newly-Diagnosed Multiple Myeloma Patients Treated without Autologous Transplant

Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, Sanghamitra Gawai, Sitaram Ghogale, Nilesh Deshpande, Bhausaheb Bagal, Gaurav Chatterjee, Syed Khizer Hasan, Sweta Rajpal, Nikhil Patkar, Hasmukh Jain, Dhanlaxmi Lalit Shetty, Kinjalka Ghosh, Nitin Inamdar, Sachin Punatar, Anant Gokarn, Manju Sengar, Navin Khattry, Papagudi Ganesan Subramanian, Sumeet Gujral
Journal: Blood
Blood (2022) 140 (Supplement 1): 1135–1136.
https://doi.org/10.1182/blood-2022-165715
Published: 2022
Journal Articles

Phase II Clinical and Correlative Study of Carfilzomib, Lenalidomide, and Dexamethasone (CRd) in Newly Diagnosed Multiple Myeloma (MM) Patients

Neha Korde, MD, Adriana Zingone, MD, PhD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Rene Costello, Diamond Zuchlinski, RN, Marcia Mulquin, RN, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, MD, Constance Yuan, MD, PhD, Prashant Ramesh Tembhare, MD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Mark Raffeld, MD, Liqiang Xi, MD, Peter Choyke, MD, Karen Kurdziel, MD, Liza Lindenberg, MD, Seth M. Steinberg, PhD, Mark Roschewski, MD, Ola Landgren, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 732.
https://doi.org/10.1182/blood.V120.21.732.732
Published: 2012
Journal Articles

Peripheral Blood Involvement with Minimal Disease Is Common in Multiple Myeloma but Not in Smoldering Myeloma

Prashant Ramesh Tembhare, MD, Constance Yuan, MD, PhD, Neha Korde, MD, Elisabet E. Manasanch, MD, Mary Kwok, MD, Mark Roschewski, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Ola Landgren, M.D., Ph.D., Maryalice Stetler-Stevenson, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4994.
https://doi.org/10.1182/blood.V120.21.4994.4994
Published: 2012
Journal Articles

Hevylite™ Assays Detect a Hidden Immunoparesis Associated with Adverse Biology in Myeloma Precursor Disease: A Prospective Clinical Study

Rene Costello, Karina Espana, Neha Korde, MD, Mary Kwok, MD, Adriana Zingone, MD, PhD, Mary Ann Yancey, RN, Marcia Mulquin, RN, Irina Maric, MD, Katherine Calvo, MD, PhD, Prashant Ramesh Tembhare, MD, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 5065.
https://doi.org/10.1182/blood.V118.21.5065.5065
Published: 2011
Journal Articles

CD81: A Novel, Specific and Highly Sensitive Marker in Flow Cytometric Diagnosis of Plasma Cell Dyscrasia

Prashant Ramesh Tembhare, MD, Constance Yuan, MD, PhD, Neha Korde, MD, Irina Maric, MD, Katherine Calvo, MD, PhD, Mary Ann Yancey, RN, Marcia Mulquin, RN, Ola Landgren, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2880.
https://doi.org/10.1182/blood.V118.21.2880.2880
Published: 2011
Journal Articles

A Phase II Trial of IPH2101 (anti-KIR mAb) in Smoldering Multiple Myeloma

Neha Korde, MD, Jane Trepel, Mattias Carlsten, MD Ph.D, Adriana Zingone, MD, PhD, Rene Costello, Mary Ann Yancey, RN, Marcia Mulquin, RN, Irina Maric, MD, Katherine Calvo, MD, PhD, Prashant Ramesh Tembhare, MD, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Min-Jung Lee, MD, Sylvia Alarcon, George Carter, PA, Richard Childs, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2944.
https://doi.org/10.1182/blood.V118.21.2944.2944
Published: 2011